Spots Global Cancer Trial Database for Drug Use Investigation for TYKERB Tablet (All Case Investigation)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Drug Use Investigation for TYKERB Tablet (All Case Investigation)
Official Title: Drug Use Investigation for TYKERB Tablet (All Case Investigation)
Study ID: NCT01332396
Conditions
Interventions
Study Description
Brief Summary: Data on the safety and efficacy of TYKERB shall be collected from the patients in order to grasp the actual conditions of post-marketing use and assess background information on the patients.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
